Structural analysis of inhibitor binding to human carbonic anhydrase II

Protein Science

Volumn 7, Issue 12, 1998, Pages 2483-2489

  Boriack Sjodin, P Ann ^a,c   Zeitlin, Samantha ^a,d   Chen, Huang Hsing ^b   Crenshaw, Lori ^b   Gross, Sharon ^b   Dantanarayana, Anura ^b   Delgado, Pete ^b   May, Jesse A ^b   Dean, Tom ^b   Christianson, David W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ALCON RESEARCH LTD   (United States)

^c BIOGEN   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Drug design; Protein crystallography; Zinc enzyme

Indexed keywords

CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE INHIBITOR;

ARTICLE; CRYSTALLOGRAPHY; DRUG DESIGN; DRUG PROTEIN BINDING; ENZYME ACTIVE SITE; ENZYME BINDING; ENZYME LOCALIZATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0031648568     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560071201     Document Type: Article

References (26)

1. Baldwin JJ, Ponticello GS, Anderson PS, Christy ME, Murcko MA, Randall WC, Schwam H, Sugrue MF, Springer JP, Gautheron P, Grove J, Mallorga P, Viader MP, McKeever BM, Navia MA. 1989. Thienothiopyran-2-sulfonamides: Novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma. J Med Chem 32:2510-2513.
2. Becker B. 1954. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, Diamox. Am J Ophth 37:13-15.
3. Boriack PA, Christianson DW, Kingery-Wood J, Whitesides GM. 1995. Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase II influence inhibitor binding constants. J Med Chem 38:2286-2291.
4. Brünger AT, Kuriyan J, Karplus M. 1987. Crystallographic R factor refinement by molecular dynamics. Science 235:458-460.
5. Bunn AMC, Alexander RS, Christianson DW. 1994. Mapping protein-peptide affinity: Binding of peptidylsulfonamide inhibitors to human carbonic anhydrase II. J Am Chem Soc 116:5063-5068.
6. Burley SK, Petsko GA. 1988. Weakly polar interactions in proteins. Adv Protein Chem 39:125-189.
7. Chen RF, Kernohan JC. 1967. Combination of bovine carbonic anhydrase with a fluorescent sulfonamide. J Biol Chem 242:5813-5823.
8. Christianson DW, Fierke CA. 1996. Carbonic anhydrase: Evolution of the zinc binding site by nature and by design. Acc Chem Res 29:331-339.
9. CCP4. 1994. Collaborative Computational Project, Number 4. Acta Crystallogr D 50:760-763.
10. Friedenwald JS. 1949. The formation of the intraocular fluid. Am J Ophth 32:9-27.
11. Greer J, Erickson JW, Baldwin JJ, Varney MD. 1994. Application of the three-dimensional structures of protein target molecules in structure-based drug design. J Med Chem 37:1035-1054.
12. Håkansson K, Carlsson M, Svensson LA, Liljas A. 1992. Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes. J Mol Biol 227:1192-1204.
13. Håkansson K, Liljas A. 1994. The structure of a complex between carbonic anhydrase II and a new inhibitor, trifluoromethane sulphonamide. FEBS Lett 350:319-322.
14. Jain A, Whitesides GM, Alexander RS, Christianson DW. 1994. Identification of two hydrophobic patches in the active-site cavity of human carbonic anhydrase II by solution-phase and solid-state studies and their use in the development of tight-binding inhibitors. J Med Chem 37:2100-2105.
15. Kinsey VE. 1953. Comparative chemistry of aqueous humor in posterior and anterior chambers of rabbit eye. Arch Ophth 50:401-417.
16. Leslie AGW. 1992. Recent changes to the MOSFLM package for processing film and image plate data. CCP4 and ESF-EACMB Newsletter on Protein Crystallography 26.
17. Mann T, Keilin D. 1940. Sulphanilamide as a specific inhibitor of carbonic anhydrase. Nature 146:164-165.
18. Maren TH. 1987. Carbonic anhydrase: General perspectives and advances in glaucoma research. Drug Dev Res 10:255-276.
19. Nair SK, Christianson DW. 1991. Unexpected pH-dependent conformation of His64, the proton shuttle of carbonic anhydrase II. J Am Chem Soc 113:9455-9458.
20. Ponticello GS, Freedman MB, Habecker CN, Lyle PA, Schwam H, Varga SL, Christy ME, Randall WC, Baldwin JJ. 1987. Thienothiopyran-2-sulfonamides: A novel class of water-soluble carbonic anhydrase inhibitors. J Med Chem 30:591-597.
21. Prugh JD, Hartman GD, Mallorga PJ, McKeever BM, Michelson SR, Murcko MA, Schwam H, Smith RL, Sondey JM, Springer JP, Sugrue MF. 1991. New isomeric classes of topically active ocular hypotensive carbonic anhydrase inhibitors: 5-substituted thieno[2,3-b]thiophene-2-sulfonamides and 5-substituted thieno[3,2-b]thiophene-2-sulfonamides. J Med Chem 34:1805-1818.
22. Silverman DN, Lindskog S. 1988. The catalytic mechanism for carbonic anhydrase: Implications of a rate-limiting protolysis of water. Acc Chem Res 21:30-36.
23. Smith GM, Alexander RS, Christianson DW, McKeever BM, Ponticello GS, Springer JP, Randall WC, Baldwin JJ, Habecker CN. 1994. Positions of His64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors. Protein Sci 3:118-125.
24. Stams T, Chen Y, Boriack-Sjodin PA, Hurt JD, Liao J, May JA, Dean T, Laipis P, Silverman DN, Christianson DW. 1998. Structures of murine carbonic anhydrase IV and human carbonic anhydrase II complexed with brinzolamide: Molecular basis of isozyme-drug discrimination. Protein Sci 7:556-563.
25. Tu CK, Silverman DN, Forsman C, Jonsson BH, Lindskog S. 1989. Role of histidine 64 in the catalytic mechanism of human carbonic anhydrase II studied with a site-specific mutant. Biochemistry 28:7913-7918.
26. Vidgren J, Liljas A, Walker NPC. 1990. Refined structure of the acetazolamide complex of human carbonic anhydrase II at 1.9 Å. Int J Biol Macromol 12:342-344.